Status: Not yet recruiting
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
This study will evaluate the long-term safety of ARD103 cellular therapies
Participants needed: 49
Trial details
Biological sex: AllType: ObservationalSponsor: ARCE Therapeutics, Inc.Updated: Dec 8, 2025Locations: 3
Eligibility criteria
The participant has R/R AML or MDS and has previously received ARD103 CAR-T cell... [+1]
There are no specific exclusion criteria for this study